/CTVA
CTVA Stock - Corteva, Inc.
Basic Materials|Agricultural InputsNYSE
$66.29-1.00%
$0.67 (-1.00%) • Dec 19
72
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.53
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).89
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.90
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+19.4%upside
Target: $79.15
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CTVA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$65.63 – $66.95
TARGET (TP)$79.17
STOP LOSS$60.99
RISK/REWARD1:2.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.74
52W High$77.41
52W Low$53.40
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $16.91B | $17.23B | $17.45B | $15.65B | $14.22B |
| Gross Profit | $7.38B | $7.31B | $7.02B | $6.43B | $5.71B |
| Gross Margin | 43.6% | 42.4% | 40.2% | 41.1% | 40.2% |
| Operating Income | $2.10B | $2.11B | $1.93B | $1.32B | $843.00M |
| Net Income | $907.00M | $735.00M | $1.15B | $1.76B | $681.00M |
| Net Margin | 5.4% | 4.3% | 6.6% | 11.2% | 4.8% |
| EPS | $1.31 | $1.04 | $1.59 | $2.39 | $0.91 |
Company Overview
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
13
52%
Hold / Neutral
12
48%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
13 Bullish12 Neutral/Bearish
Price Targets
$67
Average Target
↑ 0.6% Upside
Now
$50
Low
$67
Average
$84
High
Based on 27 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| October 3rd 2025 | KeyBanc Capital Markets | Downgrade | Sector Weight | - |
| October 2nd 2025 | Citigroup | Downgrade | Neutral | $70 |
| October 2nd 2025 | JP Morgan | Upgrade | Overweight | $67 |
| August 13th 2025 | Barclays | Upgrade | Overweight | $84 |
| March 31st 2025 | Argus | Upgrade | Buy | $69 |
| March 13th 2025 | Goldman | Initiation | Buy | $71 |
| October 23rd 2024 | Citigroup | Initiation | Buy | $68 |
| October 16th 2024 | BofA Securities | Upgrade | Buy | $67← $59 |
| August 7th 2024 | Argus | Downgrade | Hold | - |
| April 12th 2024 | JP Morgan | Downgrade | Neutral | $57← $58 |
| March 1st 2024 | Wolfe Research | Initiation | Outperform | $67 |
| February 12th 2024 | Loop Capital | Upgrade | Buy | $65← $57 |
| February 2nd 2024 | Exane BNP Paribas | Upgrade | Neutral | $53 |
| November 27th 2023 | Berenberg | Downgrade | Hold | $52← $63 |
| November 14th 2023 | Barclays | Downgrade | Equal Weight | $50← $66 |
Earnings History & Surprises
CTVABeat Rate
89%
Last 18 quarters
Avg Surprise
+31.2%
EPS vs Estimate
Beats / Misses
16/1
1 met exactly
Latest EPS
$-0.23
Q4 2025
EPS Surprise History
Q1 24
+155.4%
$0.15vs$0.06
Q2 24
+8.1%
$0.89vs$0.82
Q3 24
+5.8%
$1.83vs$1.73
Q4 24
-61.7%
$-0.49vs$-0.30
Q1 25
+2.5%
$0.32vs$0.31
Q2 25
+29.3%
$1.13vs$0.87
Q3 25
+16.4%
$2.20vs$1.89
Q4 25
+54.6%
$-0.23vs$-0.51
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Feb 4, 2026 | $0.22 | — | — | — |
Q4 2025 | Nov 4, 2025 | $-0.51 | $-0.23 | +54.6% | ✓ BEAT |
Q3 2025 | Aug 6, 2025 | $1.89 | $2.20 | +16.4% | ✓ BEAT |
Q2 2025 | May 7, 2025 | $0.87 | $1.13 | +29.3% | ✓ BEAT |
Q1 2025 | Feb 5, 2025 | $0.31 | $0.32 | +2.5% | ✓ BEAT |
Q4 2024 | Nov 6, 2024 | $-0.30 | $-0.49 | -61.7% | ✗ MISS |
Q3 2024 | Jul 31, 2024 | $1.73 | $1.83 | +5.8% | ✓ BEAT |
Q2 2024 | May 1, 2024 | $0.82 | $0.89 | +8.1% | ✓ BEAT |
Q1 2024 | Jan 31, 2024 | $0.06 | $0.15 | +155.4% | ✓ BEAT |
Q4 2023 | Nov 8, 2023 | $-0.26 | $-0.23 | +11.5% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $1.58 | $1.60 | +1.3% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $0.93 | $1.16 | +24.7% | ✓ BEAT |
Q1 2023 | Feb 1, 2023 | $0.06 | $0.16 | +166.7% | ✓ BEAT |
Q4 2022 | Nov 3, 2022 | $-0.23 | $-0.12 | +47.8% | ✓ BEAT |
Q3 2022 | Aug 4, 2022 | $1.46 | $1.64 | +12.3% | ✓ BEAT |
Q2 2022 | May 4, 2022 | $0.82 | $0.97 | +18.3% | ✓ BEAT |
Q1 2022 | Feb 2, 2022 | $0.08 | $0.08 | 0.0% | = MET |
Q4 2021 | Nov 3, 2021 | $-0.33 | $-0.14 | +57.6% | ✓ BEAT |
Q3 2021 | Aug 5, 2021 | $1.26 | $1.40 | +11.1% | ✓ BEAT |
Latest News
Citigroup Maintains Neutral on Corteva, Raises Price Target to $70
➖ NeutralBenzinga•Dec 18, 2025, 07:16 PM•Also:
Corteva, Hexagon Form Joint Venture For 'Crop Protection Solutions; Terms Not Disclosed
📈 PositiveBenzinga•Dec 16, 2025, 01:11 PM
Wells Fargo Maintains Overweight on Corteva, Lowers Price Target to $77
➖ NeutralBenzinga•Nov 11, 2025, 02:40 PM
Corteva Expects To Repurchase About $1B Of Shares In 2025
📈 PositiveBenzinga•Nov 4, 2025, 10:38 PM
Corteva Non-GAAP EPS of -$0.23 beats by $0.24, revenue of $2.59B beats by $120M
📈 PositiveSeeking Alpha•Nov 4, 2025, 09:34 PM
Corteva shares are trading higher after the company beat Q3 estimates and raised FY25 guidance.
📈 PositiveBenzinga•Nov 4, 2025, 09:32 PM
Corteva Raises FY2025 Adj EPS Guidance from $3.00-$3.20 to $3.25-$3.35 vs $3.13 Est; Raises FY2025 Sales Guidance from $17.600B-$17.800B to $17.700B-$17.900B vs $17.603B Est
📈 PositiveBenzinga•Nov 4, 2025, 09:31 PM
Corteva Q3 Adj. EPS $(0.23) Beats $(0.53) Estimate, Sales $2.618B Beat $2.473B Estimate
📈 PositiveBenzinga•Nov 4, 2025, 09:31 PM
UBS Maintains Buy on Corteva, Lowers Price Target to $81
➖ NeutralBenzinga•Oct 30, 2025, 07:49 PM
Wells Fargo Maintains Overweight on Corteva, Lowers Price Target to $80
➖ NeutralBenzinga•Oct 16, 2025, 01:29 PM
Argus Research Maintains Buy on Corteva, Lowers Price Target to $80
📈 PositiveBenzinga•Oct 13, 2025, 12:51 PM
Mizuho Maintains Outperform on Corteva, Lowers Price Target to $78
📈 PositiveBenzinga•Oct 8, 2025, 05:08 PM
UBS Maintains Buy on Corteva, Lowers Price Target to $85
➖ NeutralBenzinga•Oct 6, 2025, 05:05 PM
Keybanc Downgrades Corteva to Sector Weight
📉 NegativeBenzinga•Oct 3, 2025, 11:38 AM
Corteva shares are trading higher after JP Morgan upgraded the stock from Neutral to Overweight and announced a $70 price target.
📈 PositiveBenzinga•Oct 2, 2025, 06:42 PM•Also:
Citigroup Downgrades Corteva to Neutral, Lowers Price Target to $67
📉 NegativeBenzinga•Oct 2, 2025, 11:37 AM•Also:
JP Morgan Upgrades Corteva to Overweight, Announces $70 Price Target
📈 PositiveBenzinga•Oct 2, 2025, 11:15 AM•Also:
Corteva shares are trading lower. The company announced it will split into two public companies.
➖ NeutralBenzinga•Oct 1, 2025, 03:00 PM
Corteva Expects Dis-Synergies Of $80M To $100M Related To Spinoff; Says Legacy Liabilities Including PFAS Obligations Will Be Retained By "New Corteva"
📉 NegativeBenzinga•Oct 1, 2025, 01:39 PM
Corteva Expects $7.8B In 2025 Net Sales For New Corteva, Representing 44% Of Total Revenue
📈 PositiveBenzinga•Oct 1, 2025, 11:01 AM
Frequently Asked Questions about CTVA
What is CTVA's current stock price?
Corteva, Inc. (CTVA) is currently trading at $66.29 per share. The stock has moved -1.00% today.
What is the analyst price target for CTVA?
The average analyst price target for CTVA is $79.17, based on 1 analyst.
What sector is Corteva, Inc. in?
Corteva, Inc. operates in the Basic Materials sector, specifically within the Agricultural Inputs industry. The company is traded on the NYSE exchange.
What is CTVA's market cap?
Corteva, Inc. has a market capitalization of $44.79 billion, making it a large-cap company.
Does CTVA pay dividends?
No, Corteva, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Basic Materials SectorAPD
Air Products and Chemicals, Inc.
$239.96
Mkt Cap: $53.4B
AU
AngloGold Ashanti Plc
$86.20
Mkt Cap: $43.5B
FNV
Franco-Nevada Corporation
$211.88
Mkt Cap: $40.8B
GFI
Gold Fields Limited
$45.16
Mkt Cap: $40.4B
MLM
Martin Marietta Materials, Inc.
$633.94
Mkt Cap: $38.2B
NTR
Nutrien Ltd.
$62.28
Mkt Cap: $30.4B
NUE
Nucor Corporation
$159.15
Mkt Cap: $36.4B
VALE
Vale S.A.
$12.72
Mkt Cap: $54.3B
VMC
Vulcan Materials Company
$291.87
Mkt Cap: $38.6B
WPM
Wheaton Precious Metals Corp.
$119.70
Mkt Cap: $54.3B
Explore stocks similar to CTVA for comparison